Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Assets (2016 - 2025)

Historic Return on Assets for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Q3 2025 value amounting to 0.35%.

  • Ironwood Pharmaceuticals' Return on Assets rose 9400.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 9400.0%. This contributed to the annual value of 0.25% for FY2024, which is 18500.0% up from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Return on Assets stood at 0.35%, which was up 9400.0% from 0.28% recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year Return on Assets high stood at 0.59% for Q2 2021, and its period low was 2.88% during Q1 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' median Return on Assets value was 0.17% (recorded in 2022), while the average stood at 0.28%.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Return on Assets tumbled by -30400bps in 2024, and later surged by 30800bps in 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Return on Assets (Quarter) stood at 0.48% in 2021, then plummeted by -66bps to 0.16% in 2022, then plummeted by -1647bps to 2.53% in 2023, then soared by 111bps to 0.28% in 2024, then increased by 27bps to 0.35% in 2025.
  • Its Return on Assets was 0.35% in Q3 2025, compared to 0.28% in Q2 2025 and 0.21% in Q1 2025.